Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

RECRUITING

Center for Lung Cancer, National Cancer Center, Goyang-si

RECRUITING

Hospital Pulau Pinang, George Town

RECRUITING

Clinical Research Alliance Inc., New Hyde Park

RECRUITING

Gachon University Gil Medical Center, Incheon

RECRUITING

Virginia Cancer Specialists, Fairfax

RECRUITING

Chungbuk National University Hospital, Cheongju-si

RECRUITING

Winship Cancer Institute of Emory University, Atlanta

RECRUITING

AdventHealth Cancer Institute, Orlando

RECRUITING

SCRI Oncology Partners, Nashville

RECRUITING

Chung Shan Medical University, Taichung

RECRUITING

University of Cincinnati Cancer Center, Cincinnati

RECRUITING

Beacon International Specialist Centre, Petaling Jaya

RECRUITING

Barbara Ann Karmanos Cancer Institute, Detroit

RECRUITING

Hospital Kuala Lumpur, Kuala Lumpur

RECRUITING

Institut Kanser Negara, Putrajaya

RECRUITING

Washington University Center for Advanced Medicine, St Louis

RECRUITING

National Cheng Kung University Hospital, Tainan City

RECRUITING

Rocky Mountain Cancer Centers, Denver

RECRUITING

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

RECRUITING

Palo Verde Hematology Oncology, Glendale

RECRUITING

University of California, Irvine Health, Orange

RECRUITING

Hospital Umum Sarawak, Kuching

RECRUITING

National Cancer Centre Singapore, Singapore

RECRUITING

Tan Tock Seng Hospital, Singapore

RECRUITING

Dana-Farber Cancer Institute, Boston

RECRUITING

Seoul National University Hospital, Seoul

RECRUITING

Severance Hospital Yonsei Cancer Center, Seoul

RECRUITING

National Taiwan University Hospital, Taipei

RECRUITING

Cambridge University Hospitals NHS Trust, Addenbrooke's Hospital, Cambridge

RECRUITING

Guy's Cancer Centre NHS Foundation Trust, London

RECRUITING

The Royal Marsden NHS Foundation Trust, London